A position paper on the treatment of hospital acquired pneumonia (HAP): do we need guidelines?
Ramphal
R
R
Department of Medicine, Division of Infectious Diseases, University of Florida, Gainesville, Florida, USA. ramphr@medmac.ufl.edu
D000900:Anti-Bacterial Agents / Q000592:standards* / Q000627:therapeutic use; D001530:Belgium; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006090:Gram-Negative Bacteria / Q000187:drug effects / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000187:drug effects / Q000302:isolation & purification; D019983:Guideline Adherence; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D017410:Practice Guidelines as Topic; D012680:Sensitivity and Specificity
D000900:Anti-Bacterial Agents